HIGHLIGHTS
- who: TCF and colleagues from the University, Changsha, China, Shenzhen Nanshan Center for Chronic Disease Control, Department of Psychiatry, Shenzhen have published the research work: Olanzapine Promotes the Occurrence of Metabolic Disorders in Conditional TCF7L2-Knockout Mice, in the Journal: (JOURNAL)
- what: To test this possibility in the model , the authors performed immunofluorescence staining to confirm the reduced expression of Tcf7l2 and to determine the expressing profile of GLP-1R in the pancreas before and after olanzapine challenge. The authors have determined the multifaceted roles of Tcf7l2, one of the strongest genetic determinants for T2D . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.